The	DT	2
Department	NNP	8
of	IN	2
Health	NNP	7
and	CC	7
Human	NNP	7
Services	NNPS	3
plans	VBZ	0
to	TO	10
extend	VB	8
its	PRP$	12
moratorium	NN	10
on	IN	12
federal	JJ	15
funding	NN	13
of	IN	15
research	NN	16
involving	VBG	17
fetal-tissue	JJ	20
transplants	NNS	18
.	.	8

Medical	JJ	2
researchers	NNS	3
believe	VBP	0
the	DT	5
transplantation	NN	14
of	IN	5
small	JJ	8
amounts	NNS	6
of	IN	8
fetal	JJ	11
tissue	NN	9
into	IN	5
humans	NNS	12
could	MD	3
help	VB	14
treat	VB	15
juvenile	JJ	18
diabetes	NN	22
and	CC	22
such	JJ	22
degenerative	JJ	22
diseases	NNS	16
as	IN	22
Alzheimer	NNP	25
's	POS	31
,	,	31
Parkinson	NNP	28
's	POS	31
and	CC	31
Huntington	NNP	31
's	POS	23
.	.	3

But	CC	3
anti-abortionists	NNS	3
oppose	VBP	0
such	JJ	5
research	NN	3
because	IN	3
they	PRP	8
worry	VBP	6
that	IN	8
the	DT	11
development	NN	17
of	IN	11
therapies	NNS	12
using	VBG	13
fetal-tissue	JJ	16
transplants	NNS	14
could	MD	9
lead	VB	17
to	TO	18
an	DT	21
increase	NN	19
in	IN	21
abortions	NNS	22
.	.	3

James	NNP	2
Mason	NNP	5
,	,	5
assistant	NN	5
secretary	NN	9
for	IN	5
health	NN	6
,	,	5
said	VBD	0
the	DT	11
ban	NN	20
on	IN	11
federal	JJ	14
funding	NN	12
of	IN	14
fetal-tissue	JJ	18
transplant	NN	18
research	NN	15
``	``	20
should	MD	9
be	VB	20
continued	VBN	21
indefinitely	RB	22
.	.	9
''	''	9

He	PRP	2
said	VBD	0
the	DT	4
ban	NN	5
wo	MD	2
n't	RB	5
stop	VB	5
privately	RB	9
funded	VBN	11
tissue-transplant	JJ	11
research	NN	16
or	CC	16
federally	RB	14
funded	VBN	16
fetal-tissue	JJ	16
research	NN	7
that	WDT	16
does	VBZ	17
n't	RB	18
involve	VB	18
transplants	NNS	20
.	.	2

Department	NN	2
officials	NNS	3
say	VBP	0
that	IN	3
HHS	NNP	8
Secretary	NNP	8
Louis	NNP	8
Sullivan	NNP	9
will	MD	4
support	VB	9
Dr.	NNP	13
Mason	NNP	13
's	POS	14
ruling	NN	10
,	,	14
which	WDT	14
will	MD	16
be	VB	17
issued	VBN	18
soon	RB	19
in	IN	19
the	DT	23
form	NN	21
of	IN	23
a	DT	26
letter	NN	24
to	TO	26
the	DT	30
acting	JJ	30
director	NN	27
of	IN	30
the	DT	34
National	NNP	34
Institutes	NNPS	31
of	IN	34
Health	NNP	35
.	.	3

Both	DT	6
Dr.	NNP	3
Mason	NNP	6
and	CC	6
Dr.	NNP	6
Sullivan	NNP	7
oppose	VBP	0
federal	JJ	9
funding	NN	7
for	IN	9
abortion	NN	10
,	,	7
as	IN	7
does	VBZ	13
President	NNP	16
Bush	NNP	14
,	,	7
except	IN	7
in	IN	18
cases	NNS	19
where	WRB	20
a	DT	24
woman	NN	24
's	POS	25
life	NN	26
is	VBZ	21
threatened	VBN	26
.	.	7

The	DT	2
controversy	NN	3
began	VBD	0
in	IN	3
1987	CD	4
when	WRB	3
the	DT	9
National	NNP	9
Institutes	NNPS	22
of	IN	9
Health	NNP	10
,	,	9
aware	JJ	9
of	IN	13
the	DT	17
policy	NN	17
implications	NNS	14
of	IN	17
its	PRP$	20
research	NN	18
,	,	9
asked	VBD	6
for	IN	22
an	DT	26
HHS	NNP	26
review	NN	23
of	IN	26
its	PRP$	29
plan	NN	27
to	TO	31
implant	VB	29
fetal	JJ	33
tissue	NN	31
into	IN	31
the	DT	36
brain	NN	34
of	IN	36
a	DT	39
patient	NN	37
suffering	NN	39
from	IN	40
Parkinson	NNPS	43
's	POS	44
disease	NN	41
.	.	3

The	DT	2
department	NN	3
placed	VBD	0
a	DT	5
moratorium	NN	3
on	IN	3
the	DT	8
research	NN	6
,	,	3
pending	VBG	3
a	DT	12
review	NN	10
of	IN	12
scientific	JJ	18
,	,	18
legal	JJ	18
and	CC	18
ethical	JJ	19
issues	NNS	13
.	.	3

A	DT	2
majority	NN	7
of	IN	2
an	DT	6
NIH-appointed	JJ	6
panel	NN	3
recommended	VBD	23
late	RB	10
last	JJ	10
year	NN	7
that	IN	7
the	DT	13
research	NN	14
continue	VB	11
under	IN	14
carefully	RB	18
controlled	JJ	18
conditions	NNS	15
,	,	23
but	CC	23
the	DT	22
issue	NN	23
became	VBD	0
embroiled	VBN	23
in	IN	24
politics	NNS	25
as	IN	24
anti-abortion	JJ	29
groups	NNS	30
continued	VBD	27
to	TO	32
oppose	VB	30
federal	JJ	34
funding	NN	32
.	.	23

The	DT	2
dispute	NN	3
has	VBZ	0
hampered	VBN	3
the	DT	7
administration	NN	7
's	POS	8
efforts	NNS	4
to	TO	10
recruit	VB	8
prominent	JJ	12
doctors	NNS	10
to	TO	14
fill	VB	12
prestigious	JJ	16
posts	NNS	14
at	IN	16
the	DT	19
helm	NN	17
of	IN	19
the	DT	22
NIH	NNP	25
and	CC	25
the	DT	25
Centers	NNPS	20
for	IN	25
Disease	NNP	28
Control	NNP	26
.	.	3

Several	JJ	2
candidates	NNS	3
have	VBP	0
withdrawn	VBN	3
their	PRP$	6
names	NNS	4
from	IN	4
consideration	NN	7
after	IN	4
administration	NN	11
officials	NNS	12
asked	VBD	9
them	PRP	12
for	IN	12
their	PRP$	16
views	NNS	14
on	IN	16
abortion	NN	21
and	CC	21
fetal-tissue	JJ	21
transplants	NNS	17
.	.	3

Antonio	NNP	2
Novello	NNP	15
,	,	2
whom	WP	2
Mr.	NNP	6
Bush	NNP	7
nominated	VBD	4
to	TO	9
serve	VB	7
as	IN	9
surgeon	NN	12
general	NN	10
,	,	2
reportedly	RB	15
has	VBZ	0
assured	VBN	15
the	DT	18
administration	NN	16
that	IN	16
she	PRP	21
opposes	VBZ	19
abortion	NN	21
.	.	15

Dr.	NNP	2
Novello	NNP	3
is	VBZ	0
deputy	NN	5
director	NN	3
of	IN	5
the	DT	9
National	NNP	9
Institute	NNP	6
of	IN	9
Child	NNP	12
Health	NNP	15
and	CC	15
Human	NNP	15
Development	NNP	10
.	.	3

Some	DT	2
researchers	NNS	3
have	VBP	0
charged	VBN	3
that	IN	4
the	DT	7
administration	NN	8
is	VBZ	5
imposing	VBG	8
new	JJ	12
ideological	JJ	12
tests	NNS	9
for	IN	12
top	JJ	16
scientific	JJ	16
posts	NNS	13
.	.	3

Earlier	JJR	3
this	DT	3
week	NN	7
,	,	7
Dr.	NNP	6
Sullivan	NNP	7
tried	VBD	0
to	TO	9
defuse	VB	7
these	DT	11
charges	NNS	9
by	IN	9
stressing	VBG	12
that	IN	13
candidates	NNS	23
to	TO	17
head	VB	15
the	DT	19
NIH	NNP	22
and	CC	22
the	DT	22
CDC	NNP	17
will	MD	14
be	VB	23
judged	VBN	24
by	IN	25
``	``	36
standards	NNS	36
of	IN	28
scientific	JJ	32
and	CC	32
administrative	JJ	33
excellence	NN	29
,	,	36
''	''	36
not	RB	26
politics	NNS	36
.	.	7

But	CC	11
the	DT	4
administration	NN	4
's	POS	5
handling	NN	11
of	IN	5
the	DT	10
fetal-tissue	JJ	10
transplant	NN	10
issue	NN	6
disturbs	VBZ	0
many	JJ	13
scientists	NNS	11
.	.	11

``	``	26
When	WRB	11
scientific	JJ	4
progress	NN	5
moves	VBZ	2
into	IN	5
uncharted	JJ	8
ground	NN	6
,	,	11
there	EX	11
has	VBZ	26
to	TO	13
be	VB	11
a	DT	15
role	NN	13
for	IN	15
society	NN	16
to	TO	19
make	VB	15
judgments	NNS	19
about	IN	20
its	PRP$	23
applications	NNS	21
,	,	26
''	''	26
says	VBZ	0
Myron	NNP	28
Genel	NNP	31
,	,	31
associate	NN	31
dean	NN	26
of	IN	31
the	DT	36
Yale	NNP	36
Medical	NNP	36
School	NNP	32
.	.	26

``	``	9
The	DT	4
disturbing	JJ	4
thing	NN	9
about	IN	4
this	DT	8
abortion	NN	8
issue	NN	5
is	VBZ	0
that	IN	9
the	DT	12
debate	NN	13
has	VBZ	10
become	VBN	13
polarized	VBN	14
,	,	15
so	IN	18
that	IN	15
no	DT	20
mechanism	NN	21
exists	VBZ	18
''	''	21
for	IN	21
finding	VBG	23
a	DT	27
middle	JJ	27
ground	NN	24
.	.	9

Yale	NNP	2
is	VBZ	0
one	CD	2
of	IN	3
the	DT	8
few	JJ	8
medical	JJ	8
institutions	NNS	4
conducting	VBG	8
privately	RB	11
funded	JJ	12
research	NN	9
on	IN	12
fetal-tissue	JJ	15
transplants	NNS	13
.	.	2

But	CC	4
Dr.	NNP	3
Genel	NNP	4
warns	VBZ	0
that	IN	4
Dr.	NNP	8
Mason	NNP	8
's	POS	9
ruling	NN	10
may	MD	5
discourage	VB	10
private	JJ	13
funding	NN	11
.	.	4

``	``	37
The	DT	3
unavailability	NN	10
of	IN	3
federal	JJ	6
funds	NNS	4
,	,	10
and	CC	10
the	DT	10
climate	NN	19
in	IN	10
which	WDT	11
the	DT	14
decision	NN	15
was	VBD	11
made	VBN	15
,	,	10
certainly	RB	19
do	VBP	37
n't	RB	19
provide	VB	19
any	DT	23
incentive	NN	21
for	IN	23
one	CD	32
of	IN	25
the	DT	30
more	RBR	29
visible	JJ	30
foundations	NNS	26
to	TO	32
provide	VB	24
support	NN	32
,	,	37
''	''	37
he	PRP	37
said	VBD	0
.	.	37

Despite	IN	14
the	DT	3
flap	NN	1
over	IN	3
transplants	NNS	4
,	,	14
federal	JJ	8
funding	NN	14
of	IN	8
research	NN	9
involving	VBG	10
fetal	JJ	13
tissues	NNS	11
will	MD	0
continue	VB	14
on	IN	15
a	DT	18
number	NN	16
of	IN	18
fronts	NNS	19
.	.	14

``	``	4
Such	JJ	3
research	NN	4
may	MD	0
ultimately	RB	4
result	VB	4
in	IN	6
the	DT	9
ability	NN	7
to	TO	11
regenerate	VB	25
damaged	JJ	13
tissues	NNS	11
or	CC	25
to	TO	16
turn	VB	25
off	RP	16
genes	NNS	16
that	WDT	18
cause	VBP	19
cancer	NN	20
''	''	25
or	CC	25
to	TO	25
regulate	VB	9
genes	NNS	25
that	WDT	26
cause	VBP	27
Down	NNP	30
's	POS	31
syndrome	NN	35
,	,	35
the	DT	35
leading	VBG	35
cause	NN	28
of	IN	35
mental	JJ	38
retardation	NN	36
,	,	35
according	VBG	35
to	TO	40
an	DT	44
NIH	NNP	44
summary	NN	41
.	.	4

The	DT	2
NIH	NNP	4
currently	RB	4
spends	VBZ	0
about	IN	6
$	$	4
8	CD	6
million	CD	6
annually	RB	4
on	IN	4
fetal-tissue	JJ	12
research	NN	10
out	IN	4
of	IN	13
a	DT	18
total	JJ	18
research	NN	18
budget	NN	14
of	IN	18
$	$	19
8	CD	20
billion	CD	20
.	.	4
